10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,713 | -26.1% | 9,690 | 0.0% | 0.10% | -25.4% |
| Q2 2023 | $541,090 | +131.5% | 9,690 | +131.3% | 0.13% | +135.1% |
| Q1 2023 | $233,760 | +53.1% | 4,190 | 0.0% | 0.06% | +54.1% |
| Q4 2022 | $152,684 | +115.0% | 4,190 | +66.9% | 0.04% | +117.6% |
| Q3 2022 | $71,000 | -74.3% | 2,510 | -58.9% | 0.02% | -73.8% |
| Q2 2022 | $276,000 | +55.1% | 6,100 | +160.7% | 0.06% | +1.6% |
| Q1 2022 | $178,000 | -75.7% | 2,340 | -52.5% | 0.06% | -59.0% |
| Q4 2021 | $734,000 | +389.3% | 4,930 | +378.6% | 0.16% | +246.7% |
| Q3 2021 | $150,000 | -84.4% | 1,030 | -79.0% | 0.04% | -83.7% |
| Q2 2021 | $961,000 | -13.6% | 4,905 | -20.2% | 0.28% | -26.8% |
| Q1 2021 | $1,112,000 | +16.6% | 6,145 | -8.8% | 0.38% | +22.8% |
| Q4 2020 | $954,000 | -1.0% | 6,735 | -12.9% | 0.31% | +5.1% |
| Q3 2020 | $964,000 | +60.7% | 7,730 | +15.1% | 0.29% | +70.8% |
| Q2 2020 | $600,000 | – | 6,715 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |